For additional details on ongoing clinical trials, please visit www.clinicaltrials.gov.
Avasopasem
- ROMAN: A Phase 3 Study to Investigate the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients with Head/Neck Cancer
- EUSOM: Phase 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
- AESOP: Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer
- A Trial of GC4419 in Patients with Critical Illness Due to
COVID-19